6533b7d3fe1ef96bd12613bf
RESEARCH PRODUCT
CETP levels rather than polymorphisms as markers of coronary risk: Healthy athlete with high HDL-C and coronary disease—effectiveness of probucol
Maurizio AvernaCesare R. SirtoriLaura CalabresiDamiano BaldassarreAngelo B. CefalùGuido Franceschinisubject
medicine.medical_specialtybusiness.industryProbucolCoronary diseasecoronary diseasepolymorphismcoronary riskCoronary riskInternal medicineCETPCardiologyMedicineHDL-CCardiology and Cardiovascular Medicinebusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2006-05-01 | Atherosclerosis |